Clinical Trial Update: S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial S0340 evaluating MRI and FDG PET for diagnosing solitary plasmacytoma was terminated, per SWOG Cancer Research Network.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasmacytoma

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Multiple Myeloma, Plasmacytoma | Phase 2 | Status: TERMINATED